| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $477K | -96.8% |
| R&D Expense | $18.4M | -26.3% |
| SG&A Expense | $16.4M | -69.9% |
| Operating Income | -$34.3M | +49.6% |
| Interest Expense | $0 | -100.0% |
| Pre-tax Income | -$33.9M | +54.0% |
| Income Tax | $13K | +102.9% |
| Net Income | -$23.2M | +68.3% |
| EPS (Basic) | -$7.28 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $30.9M | -26.8% |
| Accounts Receivable | $173K | -97.7% |
| Current Assets | $38.3M | -39.4% |
| Total Assets | $40.8M | -39.2% |
| Long-term Debt | $0 | — |
| Total Liabilities | $9.3M | -49.2% |
| Stockholders' Equity | $31.2M | -35.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$29.2M | +48.2% |
| Investing Cash Flow | $15.7M | +1425.5% |
| Financing Cash Flow | $1.7M | -95.8% |
| -612.7% |
| EPS (Diluted) | -$7.28 | -612.7% |